Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 6 studies | 22% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2645.45 | 652 / 653 | 88% | 31.89 | 531 / 605 |
kidney | 100% | 2148.04 | 89 / 89 | 83% | 16.52 | 750 / 901 |
adrenal gland | 100% | 3159.19 | 258 / 258 | 47% | 18.16 | 109 / 230 |
stomach | 59% | 858.97 | 211 / 359 | 72% | 11.26 | 206 / 286 |
esophagus | 39% | 1766.87 | 561 / 1445 | 82% | 15.32 | 150 / 183 |
brain | 79% | 1387.28 | 2080 / 2642 | 41% | 5.31 | 290 / 705 |
intestine | 26% | 163.70 | 253 / 966 | 78% | 12.16 | 413 / 527 |
pancreas | 11% | 47.35 | 36 / 328 | 89% | 17.28 | 158 / 178 |
ovary | 2% | 11.54 | 4 / 180 | 94% | 17.08 | 406 / 430 |
skin | 72% | 1715.81 | 1305 / 1809 | 19% | 2.14 | 92 / 472 |
lymph node | 0% | 0 | 0 / 0 | 90% | 16.44 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 84% | 10.35 | 38 / 45 |
uterus | 5% | 49.94 | 9 / 170 | 75% | 15.07 | 345 / 459 |
lung | 4% | 15.83 | 21 / 578 | 70% | 7.89 | 812 / 1155 |
breast | 29% | 214.07 | 133 / 459 | 34% | 3.48 | 380 / 1118 |
bladder | 0% | 0 | 0 / 21 | 58% | 6.97 | 290 / 504 |
liver | 0% | 0 | 0 / 226 | 15% | 1.65 | 60 / 406 |
prostate | 4% | 26.19 | 11 / 245 | 1% | 0.09 | 7 / 502 |
eye | 0% | 0 | 0 / 0 | 5% | 0.27 | 4 / 80 |
peripheral blood | 4% | 25.28 | 40 / 929 | 0% | 0 | 0 / 0 |
adipose | 1% | 3.82 | 8 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.25 | 2 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.83 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0035556 | Biological process | intracellular signal transduction |
GO_1903861 | Biological process | positive regulation of dendrite extension |
GO_0046580 | Biological process | negative regulation of Ras protein signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0046872 | Molecular function | metal ion binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | RASAL1 |
Protein name | RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) |
Synonyms | RASAL |
Description | FUNCTION: Probable inhibitory regulator of the Ras-cyclic AMP pathway . Plays a role in dendrite formation by melanocytes . . |
Accessions | ENST00000546530.5 [O95294-3] O95294 ENST00000548055.2 [O95294-4] ENST00000261729.9 [O95294-1] ENST00000446861.7 [O95294-2] |